OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT
Yufei Liang, Shengmian Li, Guoqi Zheng, et al.
Acta Histochemica (2020) Vol. 122, Iss. 4, pp. 151538-151538
Closed Access | Times Cited: 16

Showing 16 citing articles:

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
Zhangfeng Zhong, Chi Teng Vong, Feiyu Chen, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1246-1279
Open Access | Times Cited: 76

Terpenoids from Curcumae Rhizoma: Their anticancer effects and clinical uses on combination and versus drug therapies
Yi Chen, Zongping Zhu, Jiao Chen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111350-111350
Open Access | Times Cited: 79

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
Juwon Lee, Youngjin Han, Wenyu Wang, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 48

Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer
Meenakshi Gupta, Kumari Chandan, Maryam Sarwat
Seminars in Cancer Biology (2022) Vol. 86, pp. 214-232
Closed Access | Times Cited: 36

Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
MyongHak Ri, Juan Ma, Xuejun Jin
Journal of Ethnopharmacology (2021) Vol. 281, pp. 114370-114370
Closed Access | Times Cited: 35

Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 5

Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer
Lingjie Luo, Caiji Lin, Pengfei Wang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 12, pp. 2315-2328
Open Access | Times Cited: 9

The complementary and alternative roles of elemene injection in cancer: An umbrella review
Jixin Chen, Shuqi Chen, Huiyan Luo, et al.
Pharmacological Research (2023) Vol. 198, pp. 107007-107007
Open Access | Times Cited: 9

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy
Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 2

Anticancer natural products targeting immune checkpoint protein network
Kyung‐Soo Chun, Do‐Hee Kim, Pawan Kumar Raut, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 1008-1032
Closed Access | Times Cited: 15

Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma
Rong Qiu, Wenxi Wang, Juan Li, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 7, pp. 6633-6645
Closed Access | Times Cited: 9

A Comprehensive Mini-Review of Curcumae Radix: Ethnopharmacology, Phytochemistry, and Pharmacology
Dongyi Hu, Jiayu Gao, Xiao Yang, et al.
Natural Product Communications (2021) Vol. 16, Iss. 5, pp. 1934578X2110206-1934578X2110206
Open Access | Times Cited: 3

Page 1

Scroll to top